NeuroBo Pharmaceuticals Inc. (NRBO) Social Stream



NeuroBo Pharmaceuticals Inc. (NRBO): $3.58

0.26 (-6.77%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add NRBO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#324 of 357

in industry

NEUROBO PHARMACEUTICALS INC (NRBO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering NEUROBO PHARMACEUTICALS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-31 1 $16 $16 $16 $4.04 296.04%
2022-12-07 2 $6 $6 $6 $4.04 48.51%
2023-08-29 1 $6 $6 $6 $4.04 48.51%
NA 1 $NA $NA $NA $4.04 NA%

Price Target Last Issued August 29, 2023

The Trend in the Analyst Price Target


NRBO's average price target has moved up $32 over the prior 24 months.

NRBO reports an average of 3,826.26% for its upside potential over the past 98 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-23 1 6 6 6 0.613 878.79%
2023-08-29 1 6 6 6 0.500 1100%
2023-08-29 1 48 48 48 0.500 9500%

NRBO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 24 months, NRBO's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NRBO as an investment opportunity.

  • NRBO has a higher number of analysts covering the stock than 5.66% of all US stocks.
  • In terms of how NEUROBO PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than nearly 100% of that group.
  • In terms of how NEUROBO PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 119.06% of that group.
  • NRBO has a higher upside potential (average analyst target price relative to current price) than 219.92% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, MBRX, ENLV, and AKTX are the three stocks most similar to NEUROBO PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Is NRBO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!